Thresholds are frequently thought to be involved in the development of discrete structures in response to a shallow, monotonic gradient of morphogenetic information. We propose a mechanism for threshold setting that incorporates two essential components: (i) determinator genes that produce intracellular "determinators" that control cellular differentiation during development and (i) intracellular "inhibitors" that bind tightly and specifically to the determinators to form "determinator-inhibitor pairs" that are inactive with respect to determinator function. The interaction of these components amplifies the intracellular response to an extracellular morphogen, thus producing a sharp transition in determinator gene activity. This system could operate at either the RNA level with the determinator-inhibitor pairs taking the form of sense-antisense RNAs or at the protein level via a competitive inhibition mechanism. In either case this model suggests a possible role for pseudogenes in development as a source of the intracellular inhibitors.
The process of development in complex multicellular organisms is characterized by a series of quantized decisions as cells become progressively more restricted in their potential (1) . Typically these decisions represent choices made at bidirectional branch points in pathways leading to development of different cell lineages and/or discrete structures (2, 3) . In many cases, these decisions seem to be based on the interaction of an extracellular source of morphogenetic information and an intracellular mechanism that facilitates an appropriate response to the extracellular morphogen (4) (5) (6) (7) (8) .
The concept of morphogenetic information in the form of a shallow, monotonic gradient extending over a large distance has frequently been imposed as the extracellular phenomenon governing ordered differentiation in embryogenesis (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) . The intracellular response is assumed to involve specific macromolecules that have been called "determinators" (16) . These determinators establish cellular commitment or determination, by interacting with, and thus predisposing the eventual expression of, an appropriate set of "differentiation" genes that are ultimately responsible for the development of an observable cellular phenotype. In cases where such differentiation involves the development of segments or other discrete structures, it has been proposed that the intracellular response involves thresholds that translate the monotonic gradient into a step function (17) . However, a specific mechanism defining this threshold effect at the molecular level, so as to account for specific gene expression, has yet to emerge.
A key requirement ofan intracellular threshold mechanism is the production of sharp transitions in response to the monotonic morphogenetic signal. The direct transcriptional response of a determinator gene to a regulatory molecule as described by the mass action equation does not give step functions. For example, transcription of the lac operon is proportional to the fraction of lac operator free of lac repressor (18) . In this example, and others, allostery sharpens the response to the inducer, but the transition is still not sufficiently acute (17, 18) . Thus an additional mechanism seems necessary to satisfactorily account for the signal amplification and threshold setting required to control the quantized decisions during development of multicellular organisms. We have found that by imposing the presence of an intracellular macromolecular inhibitor capable of tightly complexing with the determinator gene product, the necessary sharp intracellular transition can be realized. The system then becomes more akin to a buffered acid-base titration. Furthermore, by postulating different determinator-inhibitor pairs (D-I pairs) controlling the development of different discrete structures, the occurrence of multiple thresholds in response to a single gradient is facilitated.
There are two paramount requirements of the inhibitor molecules in this mechanism: each must be highly specific for its paired determinator molecule, and the binding coefficient for each pair must be relatively high. These requirements could be met either at the RNA level via an interaction of sense-antisense RNA or at the protein level, perhaps on the basis of competition between functional and nonfunctional subunits. In either case this suggests a potential function for pseudogenes not previously considered. Thus we propose that pseudogenes could play a significant role in morphogenesis as a source of intracellular inhibitor molecules. The D-I Model A fundamental version of our model is shown in Fig. 1 . This version assumes an extracellular morphogen present in a monotonic concentration gradient and responsible for bestowing an overall order upon cellular differentiation within a particular morphogenetic field, and an intracellular (or intranuclear) mechanism that mediates the appropriate response to the extracellular morphogen. Central to the intracellular response mechanism are a determinator that is transcriptionally regulated, its paired inhibitor that is produced constitutively, and a cytoplasmic receptor that interacts with the morphogen as it enters the cell. The determinator is the intracellular macromolecule ultimately responsible for setting commitment to a certain cell lineage or differentiation pathway. The inhibitor is an intracellular macromolecule that binds tightly to the determinator forming a complex (D-I) that is inactive with respect to determinator function.
The receptor complexes with the morphogen to form a receptor-morphogen complex that, in this version of the model, acts to repress transcription from the determinator gene. Clearly, activation rather than repression could be readily accommodated. The key point is that the rate of transcription of the determinator gene directly reflects the level of morphogen in the extracellular environment. Actual Abbreviation: D-I, determinator-inhibitor.
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where Dt is the concentration of total determinator, It is the concentration of total inhibitor, DI is the concentration of determinator-inhibitor complex, and K is the equilibrium constant. Eq. 1 can easily be solved for DI as a function of Dt, It, and K. In addition, conservation of mass requires: Df = Dt -DI, [2] where Df is the concentration ofdeterminator free ofinhibitor and thus active. Eqs. 1 and 2, together, then give Df as a function ofDt. We assume that the rate oftranscription ofthe determinator gene is inversely proportional to the concentration of morphogen. Thus Eqs. 1 and 2 are sufficient to calculate active Df as a function of the concentration of morphogen. Fig. 2 illustrates the response of active determinator to the extracellular signal as a function of the binding constant (K).
When It is several orders of magnitude greater than K, there is a sharp threshold for the transition to the presence of significant intracellularDf. By the time Kis four or five orders of magnitude less than It, the transition is virtually a step function, thus: Df = 0 when Dt < It; Df > 0 when Dt > It.
[3]
[4]
There will be essentially no change in Df in response to the decreasing concentration of morphogen or receptor-morphogen complex until Dt = It, from which point Df will increase rapidly. Thus it is It that sets the threshold at which Df will appear and subsequently induce cellular determination. Consider the following application of this model. Suppose that the constitutive production of a particular inhibitor results in a constant level of approximately 10,000 molecules per cell. This is equivalent to an intracellular concentration of about 10-8 M and is similar to the concentration of regulatory molecules (repressor) in Escherichia coli (18) . Also assume that K for this D-I pair is 10-14 M or less (a reasonable value for either protein-protein or RNA-RNA interactions). Then as long as the rate of transcription of the determinator gene is such that Dt < It, there will be essentially no Df. However, as determinator gene transcription increases in response to a drop in morphogen concentration, a point will be reached where Dt becomes equal to and then surpasses It, and from this point on the concentration ofDf will increase rapidly. By using Eqs. 1 
Predictions and Potential Experimental Verification
Mutant Phenotypes. A number of specific mutant phenotypes are predicted by the mechanism shown in Fig. 1 , regardless of the particular system to which it is applied or If the inhibitors act at the protein level, then they should be identifiable, for example, as proteins that modify the electrophoretic migration of determinator proteins. Antibodies directed against determinator proteins coupled with immunoblot techniques could facilitate this identification. The relative timing of expression of such determinator and inhibitor proteins as well as their pairing could be monitored during development.
Specific Applications
The D-I concept was originally conceived independent of any specific biological system. However, in analyzing its potential application to known systems, we have found that various facets of the model can be directly applied with good success to various biological systems.
The differentiation of segments in Drosophila is perhaps the best studied system of ordered development of discrete structures and is one of the few systems in which true determinator genes have been described (9, 10, 19) . Lewis (9) has described the development of all segments posterior to the second thoracic segment as being under the control of the bithorax gene complex (BX-C). On the basis of his studies on several mutants of the BX-C, Lewis developed a model describing the genetic control of segment differentiation in Drosophila (9) . He and others have provided evidence that expression of at least one gene or portion of the BX-C is associated with the differentiation of each segment posterior to the second thoracic segment, and he has proposed that this sequential gene expression occurs in response to an anterior-posterior gradient of repressor. Similar data is now also forthcoming for the antennapedia complex (ANT-C) that controls the development of segments anterior to the second thoracic segment (10, 20) .
Although we expect the final intricacies of the bithorax system to prove much more complex than the scheme shown in Fig. 1 , we find that by equating the BX.C genes with our determinator genes, and the repressor gradient with our extracellular morphogen gradient, the model shown comes remarkably close to explaining the following key features. (i) sharp intersegmental transcriptional boundaries for each BX-C gene; (ii) repression or derepression of a given BX-C gene mediated by a cis-regulatory element; (iii) individual derepression of each BX-C gene; (iv) overall negative control of the BX-C maintained by a major regulatory gene; (v) continued derepression of each particular BX-C gene in all segments posterior to the segment in which each is first expressed; and (vi) a sequential increase in the number of BX-C genes in the derepressed state in sequentially more posterior segments.
The specific application of our model to segmentation in Drosophila is consistent with a scheme in which the morphogen, or a precursor thereof, is laid down maternally in a static gradient maintained in a gel-like state in the ooplasm. Then, embryonic expression of the gene producing the receptor would serve to initiate the binding of morphogen to receptor forming a receptor-morphogen complex and thus facilitate the interpretation of the positional information. This interpretation would involve the translation of the monotonic gradient into a step function via the threshold-setting mechanism, resulting in the stepwise, sequential expression of BX-C-or ANT-C-like determinator genes. Each active determinator thus produced would, in turn, coordinate the expression of appropriate batteries of differentiation genes within each segment. The recent discovery of the homeobox sequence in the 3' region of several determinator genes in Drosophila (21) would seem to provide a clue to the mechanism by which these genes interact with various differentiation genes. By encoding a protein domain capable of binding DNA, the homeobox sequence apparently enables each determinator protein to interact with appropriate regions of various differentiation genes. Thus the homeobox sequence is apparently involved in regulating expression of differentiation genes, but would have no effect on establishing the pattern of determinator gene expression.
To date, no pseudogenes or other candidates for inhibitor genes in the bithorax system have been reported, and this is one current limitation on the complete application of the model to this system. However, the possibility that such genes do exist represents a testable prediction. D-I pairs could also be used in development as a counting mechanism, the, most important of which would be to count cell divisions. If a stable inhibitor is in excess when its synthesis ceases at a developmental branch point, no effect will be seen until it decreases to a concentration below that of the determinator. For example, if the inhibitor were in 10-fold excess, the cell would differentiate only after the fourth division. This type of counting mechanism could contribute to models such as that of the progress zone proposed to account for proximal-distal pattern formation in vertebrate limb development (22) . Similarly, a D-I mechanism could be involved in the onset of transcription in early Xenopus embryos where there is evidence that a D-I titration effect initiates RNA synthesis at cleavage cycle 12 (23) . Defects in a cell-counting mechanism could lead to heterochronic mutants such as those observed in Caenorhabditis elegans (24) . These mutants would be essentially analogous to the gain or loss of function mutants discussed above.
We believe the D-I mechanism has wide potential application to various developmental systems and as a general mechanism of gene regulation and threshold setting. However, it is important to note that this mechanism generally does not exclude but rather would enhance most other mechanisms of gene control or threshold setting. Even in the example shown in Fig, 1, signal An important consideration regarding the feasibility of D-I pairing at the RNA level is whether RNA-RNA hybridization could occur at sufficiently rapid rates in vivo. Evidence from both prokaryotic and eukaryotic systems would argue that it can. Mizuno et al. (26) found that translation of mRNA for the omp F gene in E. coli is inhibited by hybridization with homologous, antisense RNA under certain conditions. Coleman et al. (27) have demonstrated that similar inhibition can be engineered by expression of antisense RNAs homologous to three E. coli genes, lipoprotein, omp C, and omp A. Simons and Kleckner (28) showed that binding of a small antisense RNA to an homologous mRNA is sufficient to block the transposition function normally encoded by this message. There is also the observation of Saito and Richardson (29) regarding a translational block in a mutant of the bacteriophage T7 produced by the binding of an antisense RNA to the ribosome-binding site of an homologous mRNA. No such evidence has yet to emerge from any naturally occurring eukaryotic system, although the discovery of a short antisense RNA transcribed from the opposite strand of the 5' flanking region of the mouse dihydrofolate reductase gene (30) is intriguing in this regard. It has been shown that antisense RNA introduced into a host cell is capable of blocking infection of certain strains of virus (31, 32) . In addition, Izant and Weintraub (33, 34) showed that the simultaneous injection of sense and antisense RNA-producing herpes TK genes into mouse L cells in culture resulted in a significant reduction in TK production and that the introduction of plasmid DNA directing the production of appropriate antisense RNAs can specifically inhibit the expression of endogenous genes as well. Finally, Melton (35) has demonstrated the complete inhibition of p-globin production from mRNA injected into frog eggs by the prior injection of the appropriate antisense RNA (36) . In many cases, the level of antisense RNA required to completely inhibit a corresponding functional gene may depend on the intracellular proximity of the sense-and antisense-producing genes.
In considering the production of an antisense inhibitor RNA, it must be remembered that it will not generally contain the sequence-specific signals for posttranscriptional processing that are present in the homologous sense RNA. Thus it will not be spliced to form a direct counterpart of the fully processed sense-strand message. This may not pose any problem for the inhibitory mechanism, but if this is indeed a significant consideration, it would seem that evolution has provided the necessary source for directly homologous antisense RNA in the form of that produced from intronless pseudogenes.
Summary
The model described here provides a partial molecular basis for the differentiation of discrete structures in response to a shallow, monotonic gradient of morphogenetic information. The essence of this threshold-setting mechanism is the proposed existence of tightly-binding D-I pairs, and the corollary idea that pseudogenes could represent a source of the inhibitor. This model seems appealing in that both the evolution of its components, and the proposed mechanism by which they interact are relatively straight forward. A number of testable predictions and potential experimental verifications have been put forth which, along with results from other systems not discussed here, should eventually determine the validity of this model.
